| Targeting of tumor-associated macrophages made possible by PEG-sheddable, mannose-modified nanoparticles S Zhu, M Niu, H O’Mary, Z Cui Molecular pharmaceutics 10 (9), 3525-3530, 2013 | 234 | 2013 |
| Nanomedicine delivers promising treatments for rheumatoid arthritis LK Prasad, H O'Mary, Z Cui Nanomedicine 10 (13), 2063-2074, 2015 | 124 | 2015 |
| Lipid nanoparticles with minimum burst release of TNF-α siRNA show strong activity against rheumatoid arthritis unresponsive to methotrexate AM Aldayel, HL O'Mary, SA Valdes, X Li, SG Thakkar, BE Mustafa, Z Cui Journal of Controlled Release 283, 280-289, 2018 | 98 | 2018 |
| The effect of the acid-sensitivity of 4-(N)-stearoyl gemcitabine-loaded micelles on drug resistance caused by RRM1 overexpression S Zhu, P Wonganan, DSP Lansakara-P, HL O'Mary, Y Li, Z Cui Biomaterials 34 (9), 2327-2339, 2013 | 68 | 2013 |
| Acid-sensitive sheddable PEGylated PLGA nanoparticles increase the delivery of TNF-α siRNA in chronic inflammation sites AM Aldayel, YW Naguib, HL O'mary, X Li, M Niu, TB Ruwona, Z Cui Molecular Therapy-Nucleic Acids 5, 2016 | 49 | 2016 |
| Nanomedicine for Intra-Articular Drug Delivery in Rheumatoid Arthritis. H O'Mary, I del Rincόn, Z Cui Current Medicinal Chemistry 23 (23), 2490 - 2506, 2016 | 20 | 2016 |
| Acid-sensitive sheddable PEGylated, mannose-modified nanoparticles increase the delivery of betamethasone to chronic inflammation sites in a mouse model HL O’Mary, AM Aldayel, SA Valdes, YW Naguib, X Li, K Salvady, Z Cui Molecular pharmaceutics 14 (6), 1929-1937, 2017 | 16 | 2017 |
| Effect of the ratio of betamethasone to TNF-α siRNA Coencapsulated in solid lipid nanoparticles on the acute Proinflammatory activity of the nanoparticles HL O’Mary, MS Hanafy, AM Aldayel, SA Valdes, RF Alzhrani, S Hufnagel, ... Molecular pharmaceutics 16 (11), 4496-4506, 2019 | 10 | 2019 |
| Injectable Formulations of Poorly Water-Soluble Drugs YW Naguib, HL O’Mary, Z Cui, AB Watts Formulating Poorly Water Soluble Drugs, 257-293, 2016 | 3 | 2016 |
| Combination 5-Fluorouracil and Microneedling Therapy for Wound Modification: A Histological Murine Study AH Watson, HL O’Mary, Z Cui, SC Baer, MB Somogyi, N Homer, ... The American Journal of Cosmetic Surgery 40 (2), 102-112, 2023 | 2 | 2023 |
| Effect of nanoparticle size on their distribution and retention in chronic inflammation sites AM Aldayel, S Hufnagel, HL O’Mary, SA Valdes, RF Alzhrani, H Xu, Z Cui Discover Nano 18 (1), 105, 2023 | 1 | 2023 |
| Discover Nano AM Aldayel, S Hufnagel, HL O’Mary, SA Valdes, RF Alzhrani, H Xu, Z Cui | | 2023 |
| Lipid-based nanoparticles for encapsulation and sustained release of therapeutic agents Z Cui, A Aldayel, OM Hannah US Patent 11,529,314, 2022 | | 2022 |
| Injectable Formulations of Poorly Water-Soluble Drugs HL O’Mary, Z Cui Formulating Poorly Water Soluble Drugs, 217-252, 2022 | | 2022 |
| Nanoparticle-mediated delivery of anti-inflammatory therapies HL O'Mary | | 2019 |
| A Novel TNF-α siRNA Nano-Formulation for Potential Treatment of Arthritis A Aldayel, H O'Mary, S Valdes, X Li, S Thakkar, Z Cui AAPS Annual Meeting, 2017 | | 2017 |
| A Novel Acid-Sensitive TNF-α siRNA Nano-formulation for Potential Treatment of Chronic Inflammation A Aldayel, Y Naguib, H O'Mary, X Li, M Niu, T Ruwona, Z Cui AAPS Annual Meeting, 2016 | | 2016 |
| Acid-Sensitive Sheddable PEGylated Nanoparticles for Targeted Delivery to Chronic Inflammation Sites H O'Mary, Z Cui AAPS Annual Meeting, 2016 | | 2016 |
Abdulaziz M AldayelKAIMRC, University of Texas at AustinVerified email at utexas.edu
